Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 8,001–8,020 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Prostaglandin 40 mcg/mL, Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Prostaglandin 20 mcg/mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Polyhexamethylene Biguanide 0.02% Ophthalmic Drops, 2 mL Dropper, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine 1 mg/mL Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Penicillin G 100,000/mL 10 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Morphine Sulfate 5 mg/3mL Inhalation, 3 mL Vials, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Methylprednisolone 1% PF Ophthalmic, 3 mL Droppers, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Methylcobalamin 1 mg/mL Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Methionine 15mg/Choline 100mg/ Inositol 50mg/ Methylcobalamin 1mg/ Lidocoaine 10 mg, benzyl alcohol/ water, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Heparin 2 mL/Lidocaine 2%-10 mL/Sodium Bicarbonate 8.4%-5mL/ Sterile Water 10 mL, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Heparin 10 mL/Marcain 0.25% 20 mL/Sodium Bicarbonate 8.4%-40 mL/per 70 mL, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Heparin 10,000 U/Bupivacaine 0.5% 10 mL, Sodium Bicarbonate 8.4% 50 mL, 61 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Heparin 10 mL/ Marcain 0.25% 20 mL/Sodium Bicarbonate 8.4%-40 mL/ Normal Saline 5 mL, 60 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Heparin 20,000 U/Lidocaine 2% 10 mL/Sodium Bicarbonate 8.4% 10 mL/Sterile Water 5 mL, 27 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG 40 Day Injection Extra Strength, vials, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG 4,100 Units/vial Injection, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG 23 Day Injection Extra Strength, vials, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN 1-800-263-8890

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG 20,000 units/vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG 20 Day Extra Strength, 3500 Units/4 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG 30 Day, 3750 Units/6 mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN 1-800-263-8890

by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

Reason
Lack of sterility assurance.
Recall initiated
April 2, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.